NICOTROL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Nicotrol, and when can generic versions of Nicotrol launch?
Nicotrol is a drug marketed by Mcneil Cons, Pfizer, and Pfizer Inc. and is included in three NDAs.
The generic ingredient in NICOTROL is nicotine. There are thirty drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the nicotine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nicotrol
A generic version of NICOTROL was approved as nicotine by AVEVA on October 20th, 1997.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NICOTROL?
- What are the global sales for NICOTROL?
- What is Average Wholesale Price for NICOTROL?
Summary for NICOTROL
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 3 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 105 |
Clinical Trials: | 16 |
Patent Applications: | 5,077 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for NICOTROL |
What excipients (inactive ingredients) are in NICOTROL? | NICOTROL excipients list |
DailyMed Link: | NICOTROL at DailyMed |
![NICOTROL drug patent expirations Drug patent expirations by year for NICOTROL](/p/graph/s/t/NICOTROL-patent-expirations.png)
![Drug Prices for NICOTROL](/p/graph/drug-price/NICOTROL.png)
Recent Clinical Trials for NICOTROL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Institute on Drug Abuse (NIDA) | Early Phase 1 |
National Institute of Mental Health (NIMH) | Phase 2 |
Duke University | Early Phase 1 |
Pharmacology for NICOTROL
Drug Class | Cholinergic Nicotinic Agonist |
US Patents and Regulatory Information for NICOTROL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mcneil Cons | NICOTROL | nicotine | FILM, EXTENDED RELEASE;TRANSDERMAL | 020536-001 | Jul 3, 1996 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Pfizer | NICOTROL | nicotine | INHALANT;ORAL | 020714-001 | May 2, 1997 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Pfizer Inc | NICOTROL | nicotine | SPRAY, METERED;NASAL | 020385-001 | Mar 22, 1996 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for NICOTROL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pfizer | NICOTROL | nicotine | INHALANT;ORAL | 020714-001 | May 2, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Pfizer | NICOTROL | nicotine | INHALANT;ORAL | 020714-001 | May 2, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Mcneil Cons | NICOTROL | nicotine | FILM, EXTENDED RELEASE;TRANSDERMAL | 020536-001 | Jul 3, 1996 | ⤷ Sign Up | ⤷ Sign Up |
Pfizer | NICOTROL | nicotine | INHALANT;ORAL | 020714-001 | May 2, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Pfizer Inc | NICOTROL | nicotine | SPRAY, METERED;NASAL | 020385-001 | Mar 22, 1996 | ⤷ Sign Up | ⤷ Sign Up |
Mcneil Cons | NICOTROL | nicotine | FILM, EXTENDED RELEASE;TRANSDERMAL | 020536-001 | Jul 3, 1996 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for NICOTROL
See the table below for patents covering NICOTROL around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
China | 1016843 | ⤷ Sign Up | |
Ireland | 911956 | ⤷ Sign Up | |
Australia | 4031289 | ⤷ Sign Up | |
China | 1059649 | ⤷ Sign Up | |
Japan | 3830158 | ⤷ Sign Up | |
Austria | 182070 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |